Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines

Historically, vaccine development has been heavily supported by government and public institutions. On the other hand, private biopharmaceutical companies have played a significant role in the development of innovative new therapies using novel pharmaceutical technologies. COVID-19 vaccines using ne...

Full description

Saved in:
Bibliographic Details
Main Author: Ryo Okuyama
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Journal of Market Access & Health Policy
Subjects:
Online Access:https://www.mdpi.com/2001-6689/12/4/25
Tags: Add Tag
No Tags, Be the first to tag this record!